← Evidence map

ReviewCurrent pharmaceutical biotechnology2012

Oncolytic HSV-1 virotherapy: clinical experience and opportunities for progress.

Balveen Kaur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

43 papers cite it

2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 21740359